GAO on "IP" and drug innovation

Speaking here of drugs Congress likes– patented pharmaceuticals– the GAO says:

Intellectual property protections are designed to help encourage innovation by providing financial incentives to engage in research and development efforts.

but, according to some experts interviewed by GAO

intellectual property protections enable companies to earn significant profits while reducing the incentive to develop more innovative drugs.

Nothing really new here. GAO wasn’t asked to provide any recommendations.  Full report is here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.